Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
337.59
+4.62 (1.39%)
At close: Nov 10, 2026, 4:00 PM EST
336.50
-1.09 (-0.32%)
Pre-market: Nov 11, 2026, 4:10 AM EST
PRAX Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, PRAX stock has a consensus rating of "Strong Buy" and an average price target of $653. The average 1-year stock price forecast is 93.43% higher than the current stock price, while the lowest is $189 (-44.01%) and the highest is $1,201 (+255.76%).
Price Target: $653 (+93.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 14 | 14 | 15 | 15 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 19 | 19 | 19 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $706 | Buy | Maintains | $706 | +109.13% | Nov 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $650 | Buy | Reiterates | $650 | +92.54% | Nov 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $462 → $478 | Buy | Maintains | $462 → $478 | +41.59% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1,201 | Buy | Reiterates | $1,201 | +255.76% | Nov 10, 2026 |
| BTIG | BTIG | Buy Maintains $826 | Buy | Maintains | $826 | +144.68% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
384.62K
Revenue Next Year
346.41M
from 384.62K
Increased by 89,966.55%
EPS This Year
-13.22
from -13.48
EPS Next Year
-9.70
from -13.22
EPS and Forward PE are based on non-GAAP adjusted numbers.